Luigi Fattore

miR-579-3p controls melanoma progression and resistance to target therapy

Luigi Fattore, Rita Mancini, Mario Acunzo et al. · Proceedings of the National Academy of Sciences · 2016 · 115 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma

Maria Elena Pisanu, Marcello Maugeri‐Saccà, Luigi Fattore et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 92 citations · Full text

Medicine, Cancer Biology, Oncology +17

Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma

Luigi Fattore, Ciro Francesco Ruggiero, Maria Elena Pisanu et al. · Cell Death and Differentiation · 2018 · 71 citations · Full text

Medicine, Cancer Biology, Oncology +17

Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies

Luigi Fattore, Emanuele Marra, Maria Elena Pisanu et al. · Journal of Translational Medicine · 2013 · 69 citations · Full text

Medicine, Cancer Biology, Pharmacology +17

Selective targeting of point-mutated KRAS through artificial microRNAs

Mario Acunzo, Giulia Romano, Giovanni Nigita et al. · Proceedings of the National Academy of Sciences · 2017 · 48 citations · Full text

Life Sciences, Genetics, Molecular Biology +15